News from orexigen therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:OREX)

Feb 02, 2016, 16:15 ET

Orexigen Therapeutics to Speak at Upcoming Investor Conferences

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor conferences. The...

Jan 11, 2016, 08:30 ET

Orexigen announces 2016 financial outlook and key priorities

 Orexigen Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced key priorities...

Jan 08, 2016, 16:15 ET

Orexigen Therapeutics names Thomas Lynch as EVP, General Counsel & Secretary and Heather Ace as EVP, Global Human Resources

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced the appointment of Thomas Lynch as Executive Vice President, General Counsel &...

Jan 05, 2016, 16:01 ET

Orexigen Therapeutics to Speak at the J.P. Morgan 2016 Global Healthcare Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the J.P. Morgan 2016 Global...

Nov 25, 2015, 09:00 ET

Orexigen Therapeutics to Speak at the Piper Jaffray 27th Annual Healthcare Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will participate in a fireside chat discussion at the Piper...

Nov 06, 2015, 16:01 ET

Orexigen Therapeutics to Present at Credit Suisse 2015 Healthcare Conference

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a corporate overview at the Credit Suisse 2015...

Nov 05, 2015, 16:01 ET

Orexigen Therapeutics Reports Financial and Business Results for the Third Quarter Ended September 30, 2015

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced business and financial results for the third quarter ended September 30, 2015....

Oct 22, 2015, 16:15 ET

Orexigen Therapeutics to Provide Business Update and Discuss Third Quarter 2015 Financial Results on November 5, 2015

Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce corporate and financial results for the third quarter 2015 on Thursday, November 5 after...

Oct 01, 2015, 08:45 ET

Orexigen Announces Submission of Contrave® New Drug Application in South Korea

Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that Kwang Dong Pharmaceutical Company, Ltd., has filed a New Drug Application with the...

Sep 23, 2015, 08:30 ET

Orexigen Receives Payments Totaling $22 Million from U.S. and Korean Partners

Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced receipt of the first of three potential $15 million anniversary milestone payments from...

Sep 10, 2015, 09:18 ET

Orexigen Raises $60 Million in Sale of Common Stock to Baupost

Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that funds managed by The Baupost Group, L.L.C. have purchased 20 million shares of its...

Sep 04, 2015, 09:00 ET

Orexigen Therapeutics to Speak at the Wells Fargo Securities 2015 Healthcare Conference

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a corporate overview at the Wells Fargo...

Aug 06, 2015, 07:00 ET

Orexigen Therapeutics Reports Financial and Business Results for the Second Quarter Ended June 30, 2015

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced business and financial results for the second quarter ended June 30, 2015. "We...

Aug 06, 2015, 06:59 ET

Orexigen Announces Korean Distributorship Agreement with Kwang Dong Pharmaceutical Company

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that wholly-owned subsidiary Orexigen Therapeutics Ireland Ltd. and Kwang Dong...

Aug 06, 2015, 06:58 ET

Orexigen and Takeda Announce an Amended and Restated Collaboration Agreement

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) and Takeda Pharmaceutical Company Limited (TYO: 4502) today announced execution of an amended and...

Jul 24, 2015, 08:00 ET

Orexigen Therapeutics to Provide Business Update and Discuss Second Quarter 2015 Financial Results on August 6, 2015

Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce corporate and financial results for the second quarter 2015 on Thursday, August 6 before...

Jun 18, 2015, 09:00 ET

Orexigen Therapeutics to Speak at the JMP Securities Life Sciences Conference

Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that management will participate in a fireside chat discussion at the JMP Securities...

Jun 05, 2015, 08:31 ET

Orexigen Announces Upcoming Data Presentations from the Open-Label Contrave® Ignite Study at the Annual Meeting of the American Diabetes Association

Orexigen Therapeutics (NASDAQ: OREX) announced today that two Contrave® (naltrexone HCI and bupropion HCI) abstracts will be presented at the...

Jun 05, 2015, 08:30 ET

Orexigen and Takeda File Lawsuit Against Actavis for Infringement of Contrave® Patents

Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that it and its North American partner, Takeda Pharmaceuticals, have filed a lawsuit in...

May 12, 2015, 19:19 ET

Orexigen Therapeutics Provides Statement on Termination of the Light Study and Updates on Contrave Collaboration with Takeda Pharmaceuticals

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today issued the following statement regarding the termination of the Light Study a cardiovascular...